The American Journal of Medicine
Volume 119, Issue 5 , Pages 448.e1-448.e19 , May 2006

Quality of Life in Patients with Atrial Fibrillation: A Systematic Review

Received 9 July 2005 ,Accepted 31 October 2005.

References 

  1. Freestone B , Lip GYH . Epidemiology and costs of cardiac arrhythmias . In:  Lip GYH ,  Godtfredsen J editor. Cardiac Arrhythmias (A Clinical Approach) . Edinburgh: Mosby; 2003;p. 3–24
  2. Stewart S , Murphy N , Walker A , McGuire A , McMurray JJ . Cost of an emerging epidemic (an economic analysis of atrial fibrillation in the UK) . Heart . 2004;90:286–292
  3. Steinberg JS . Atrial fibrillation (an emerging epidemic?) . Heart . 2004;90:239–240
  4. Wolf PA , Mitchell JB , Baker CS , Kannel WB , D’Agostino RB . Impact of atrial fibrillation on mortality, stroke, and medical costs . Arch Intern Med . 1998;158:229–234
  5. Lim HS , Hamaad A , Lip GYH . Clinical review (clinical management of atrial fibrillation—rate control versus rhythm control) . Crit Care . 2004;8:271–279
  6. World Health Organisation . The constitution of the World Health Organisation . WHO Chronicle. . 1947;1:29
  7. Sanders C , Egger M , Donovan J , Tallon D , Frankel S . Reporting on quality of life in randomised controlled trials (bibliographic study) . BMJ . 1998;317:1191–1194
  8. Houston-Miller N . Compliance with treatment regimes in chronic asymptomatic diseases . Am J Med. . 1997;102:43–49
  9. Fitzpatrick R , Fletcher A , Gore S , Jones D , Spiegelhalter D , Cox D . Quality of life measures in health care (applications and issues in assessment) . BMJ . 1992;305:1074–1077
  10. Lüderitz B , Jung W . Quality of life in patients with atrial fibrillation . Arch Intern Med. . 2000;160:1749–1757
  11. Carlsson J , Miketic S , Windeler J , et al.  STAF Investigators   Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation (the Strategies of Treatment of Atrial Fibrillation (STAF) study) . J Am Coll Cardiol . 2003;41:1690–1696
  12. Gronefeld GC , Lilienthal J , Kuck KH , et al.  pharmacological intervention in atrial fibrillation (PIAF)   Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation . Eur Heart J. . 2003;24:1430–1436
  13. Hagens VE , Ranchor AV , Van Sonderen E , et al.  RACE Study Group   Effect of rate or rhythm control on quality of life in persistent atrial fibrillation . J Am Coll Cardiol. . 2004;43:241–247
  14. Jenkins LS , Brodsky M , Schron E , et al.   Quality of life in atrial fibrillation (the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study) . Am Heart J . 2005;149:112–120
  15. Stroup DF , Berlin JA , Morton SC , et al.   Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group . JAMA . 2000;283:2008–2012
  16. Dorian P , Jung W , Newman D , et al.   The impairment of health-related quality of life in patients with intermittent atrial fibrillation (implications for assessment of investigational therapy) . J Am Coll Cardiol. . 2000;36:1303–1309
  17. Paquette M , Roy D , Talajic M , et al.   Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation . Am J Cardiol. . 2000;86:764–768
  18. Howes CJ , Reid MC , Brandt C , et al.   Exercise tolerance and quality of life in elderly patients with chronic atrial fibrillation . J Cardiovasc Pharmacol Ther. . 2001;6:23–29
  19. van den Berg MP , Hassink RJ , Tuinenburg AE , et al.   Quality of life in patients with paroxysmal atrial fibrillation and its predictors (importance of the autonomic system) . Eur Heart J. . 2001;22:247–253
  20. Kang Y , Bahler R . Health related quality of life in patients newly diagnosed with atrial fibrillation . Eur J Cardiovasc Nurs. . 2003;3:71–76
  21. Kay GN , Bubien RS , Epstein AE , et al.   Effect of catheter ablation of the atrioventricular junction on QoL and exercise tolerance in paroxysmal atrial fibrillation . Am J Cardiol. . 1988;62:741–744
  22. Natale A , Zimerman L , Tomassoni G , et al.   Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response . Am J Cardiol. . 1996;78:1431–1433
  23. Kay GN , Ellenbogen KA , Giudici M , et al.  APT Investigators   The Ablate and Pace Trial (a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation) . J Interv Card Electrophysiol . 1998;2:121–135
  24. Marshall HJ , Harris ZI , Griffith MJ , Gammage MD . Atrioventricular node ablation and implantation of mode switching dual chamber pacemakers (effective treatment for drug refractory paroxysmal atrial fibrillation) . Heart. . 1998;79:543–547
  25. Levy T , Walker S , Rex S , Paul V . Ablate and pace for drug refractory paroxysmal atrial fibrillation. Is ablation necessary? . Int J Cardiol . 2000;75:187–195
  26. Takahashi Y , Yoshita I , Takahashi A , et al.   Av node ablation and pacemaker implantation improves hemodynamic function in atrial fibrillation . PACE. . 2003;26:1212–1217
  27. Fitzpatrick AP , Kourouyan HD , Siu A , et al.   Quality of life and outcomes after radiofrequency HIS-bundle catheter ablation and permanent pacemaker implantation (impact of treatment in paroxysmal and established atrial fibrillation) . Am J Heart . 1996;131:499–507
  28. Lee SH , Chen SA , Tai CT , et al.   Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation . J Am Coll Cardiol. . 1998;31:637–644
  29. Twidale N , McDonald T , Nave K , Seal A . Comparison of the effects of AV nodal ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation . Pacing Clin Electrophysiol . 1998;21:641–651
  30. Natale A , Zimerman L , Tomassoni G , et al.   AV node ablation and pacemaker implantation after withdrawal of effective rate-control medications for chronic atrial fibrillation . PACE . 1999;22:1634–1639
  31. Levy T , Walker S , Mason M , et al.   Importance of rate control or rate regulation for improving exercise capacity and quality of life in patients with permanent atrial fibrillation and normal left ventricular function (a randomised controlled study) . Heart . 2001;85:171–178
  32. Brignole M , Menozzi C , Gasparini M , et al.  PAF 2 Study Investigators   An evaluation of the strategy of maintenance of sinus rhythm by anti-arrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation . Eur Heart J . 2002;23:892–900
  33. Duff HJ , Raj SR , Exner DV , et al.   Randomized controlled trial of fixed rate versus rate responsive pacing after radiofrequency atrioventricular junction ablation (quality of life, ventricular refractoriness, and paced QT dispersion) . J Cardiovasc Electrophysiol . 2003;14:1163–1170
  34. Weerasooriya R , Davis M , Powell A , et al.   The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT) . J Am Coll Cardiol. . 2003;41:1697–1702
  35. Tse HF , Lam YM , Lau CP , Cheung BM , Kumana CR . Comparison of digoxin versus low-dose amiodarone for ventricular rate control in patients with chronic atrial fibrillation . Clin Exp Pharmacol Physiol . 2001;28:446–450
  36. Tse HF , Newman D , Ellenbogen KA , Buhr T , Markowitz T , Lau CP  Atrial Fibrillation SYMPTOMS investigators . Effects of ventricular rate regularization pacing on quality of life and symptoms in patients with atrial fibrillation (Atrial fibrillation symptoms mediated by pacing to mean rates [AF SYMPTOMS study]) . Am J Cardiol. . 2004;94:938–941
  37. Dierkes S , Hennersdorf MG , Vester EG , Perlings C . Long-term follow-up of right atrial multilinear high-frequency ablation in the treatment of recurrent paroxysmal atrial fibrillation . Ditsch Med Wochenschr. . 2003;128:130–134
  38. Erdogan A , Carlsson J , Neumann T , et al.   Quality of life in patients with atrial fibrillation after catheter ablation (results of long-term follow-up) . PACE . 2003;26:678–684
  39. Goldberg A , Menen M , Mickelson S , et al.   Atrial fibrillation ablation leads to long-term improvement of quality of life and reduced utilisation of healthcare resources . J Interv Cardiac Electrophysiol . 2003;8:59–64
  40. Nilsson B , Chen X , Svendsen JH . Effects of pulmonary vein isolation on quality of life in patients with paroxysmal atrial fibrillation . Heart Drug. . 2003;3:173–179
  41. Tada H , Naito S , Kurosaki K , et al.   Segmental pulmonary vein isolation for paroxysmal atrial fibrillation improves quality of life and clinical outcomes . Circ J. . 2003;67:861–865
  42. Calo L , Lamberti F , Loricchio ML , et al.   Long-term follow-up of right atrial ablation in patients with atrial fibrillation (efficacy and impact of a hybrid approach on quality of life) . J Cardiovasc Electrophysiol . 2004;15:37–43
  43. Chen MS , Marrouche NF , Khaykin Y , et al.   Pulmonary vein ablation for the treatment of atrial fibrillation in patients with impaired systolic function . J Am Coll Cardiol. . 2004;43:1004–1009
  44. Purerfellner H , Martinek M , Aichinger J , Nesser HJ , Kempen K , Janssen JP . Quality of life restored to normal in patients with atrial fibrillation after pulmonary vein ostial isolation . Am Heart J . 2004;148:318–325
  45. Gerstenfeld EP , Guerra P , Sparks PB , Hattori K , Lesh MD . Clinical outcome after radiofrequency catheter ablation of focal atrial fibrillation triggers . J Cardiovasc Electrophysiol . 2001;12:900–908
  46. Jessurun ER , van Hemel NM , Defauw JA , et al.   Results of Maze surgery for lone paroxysmal atrial fibrillation . Circulation . 2000;101:1559–1567
  47. Lonnerholm S , Blomstrom P , Nilsson L , Oxelbark S , Jideus L , Blomstrom-Lundqvist C . Effects of maze operation on health-related quality of life in patients with atrial fibrillation . Circulation. . 2000;101:2607–2611
  48. Jessurun ER , van Hemel NM , Defauw JJ , et al.   A randomized study of combining maze surgery for atrial fibrillation with mitral valve surgery . J Cardiovasc Surg. . 2003;44:9–18
  49. Berry C , Stewart S , Payne EM , McArthur JD , McMurray JJ . Electrical cardioversion for atrial fibrillation (outcomes in “real-life” clinical practice) . Int J Cardiol. . 2001;81:29–35
  50. Kale M , Bennett DH . Atrial septal pacing in the prevention of paroxysmal atrial fibrillation refractory to antiarrhythmic drugs . Int J Cardiol . 2002;82:167–175
  51. Newman DM , Dorian P , Paquette M , et al.   Effect of an implantable cardioverter defibrillator with atrial detection and shock therapy on patient-perceived, health-related quality of life . Am Heart J. . 2003;145:841–846
  52. Ricci R , Quesada A , Pignalberi C , et al.   Dual defibrillator improves quality of life and decreases hospitalizations in patients with drug refractory atrial fibrillation . J Interv Card Electrophysiol . 2004;10:85–92
  53. Dorian P , Paquette M , Newman D , et al.  CTAF Investigators   Quality of life improves with treatment in the Canadian trial of atrial fibrillation . Am Heart J. . 2002;143:984–990
  54. Krittayaphong R , Bhuripanyo K , Pooranwattanakul S , et al.   A randomised clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation . J Med Assoc Thai. . 2003;86:S8–S16
  55. Pappone C , Rosanio S , Augello G , et al.   Mortality, morbidity, and quality of life after pulmonary vein ablation . J Am Coll Cardiol. . 2003;42:185–197
  56. Channer KS , Birchall A , Steeds RP , et al.   A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation . Eur Heart J . 2004;25:144–150
  57. Vora A , Karanad D , Goyal V , et al.   Control of rate vs. rhythm in rheumatic atrial fibrillation (a randomised study) . Indian Heart J. . 2004;56:110–116
  58. Brignole M , Gianfranchi L , Menozzi C , et al.   Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation (a randomised controlled study) . Circulation . 1997;96:2617–2624
  59. Marshall HJ , Harris ZI , Griffith MJ , Holder RL , Gammage MD . Prospective randomized study of ablation and pacing versus medical therapy for paroxysmal atrial fibrillation (effects of pacing mode and mode-switch algorithm) . Circulation. . 1999;99:1587–1592
  60. Ueng KC , Tsai TP , Tsai CF , et al.   Acute and long term effects of atrioventricular junction ablation and VVIR pacemaker in symptomatic patients with chronic lone atrial fibrillation and normal ventricular response . J Cardiovasc Electrophysiol. . 2001;12:303–309
  61. Cooper HA , Bloomfield DA , Bush DE , et al.   Relationship between achieved heart rate and outcomes in patients with atrial fibrillation (AFFIRM Study) . Am J Cardiol. . 2004;93:1247–1253
  62. Wood MA , Brown-Mahoney C , Kay GN , Ellenbogen KA . Clinical outcomes after ablation and pacing therapy for atrial fibrillation (a meta-analysis) . Circulation. . 2000;101:1138–1144
  63. Dretzke J , Toff WD , Lip GY , Raftery J , Fry-Smith A , Taylor R . Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular block . Cochrane Database Syst Rev. . 2004;2:1–60
  64. Bubien RS , Knotts-Dolson SM , Plumb VJ . Effect of radiofrequency catheter ablation on health-related quality of life in patients with recurrent arrhythmias . Circulation . 1996;94:1585–1591

PII: S0002-9343(05)01067-3

doi: 10.1016/j.amjmed.2005.10.057

The American Journal of Medicine
Volume 119, Issue 5 , Pages 448.e1-448.e19 , May 2006

Article Tools

* Image Usage & Resolution